{"entity":{"type":"insider","cik":"0001485417","url":"/insider/0001485417","json_url":"/insider/0001485417.json","name":"Shannon James Samuel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2019-09-13","last":"2026-03-30","span_basis":"filed_date"},"name_variants":[{"name":"Shannon James Samuel","source":"filing","n_filings":4,"first_seen":"2019-09-13","last_seen":"2026-03-30"}],"transactions":[{"id":6088087,"accession":"0001193125-26-131745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-131745","line_url":"/filing/0001193125-26-131745#line-1","is_derivative":false,"issuer_cik":"0001485417","issuer_name":"Xilio Therapeutics, Inc.","issuer_ticker":"XLO","issuer_name_source":null,"issuer_url":"/issuer/0001485417","owner_cik":"0001485417","owner_name":"Shannon James Samuel","owner_display_name":"Shannon James Samuel","owner_url":"/insider/0001485417","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":8.79,"price_display":"8.79","price_state":"stated","total_value":43950.0,"total_display":"43,950.00","total_whole":"43,950","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-30","scope":"insider"},{"id":4920188,"accession":"0001415889-25-017705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-017705","line_url":"/filing/0001415889-25-017705#line-2","is_derivative":false,"issuer_cik":"0001485417","issuer_name":"Xilio Therapeutics, Inc.","issuer_ticker":"XLO","issuer_name_source":null,"issuer_url":"/issuer/0001485417","owner_cik":"0001485417","owner_name":"Shannon James Samuel","owner_display_name":"Shannon James Samuel","owner_url":"/insider/0001485417","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.6886,"price_display":"0.69","price_state":"stated","total_value":17215.0,"total_display":"17,215.00","total_whole":"17,215","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider"},{"id":4920184,"accession":"0001415889-25-017705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-017705","line_url":"/filing/0001415889-25-017705#line-1","is_derivative":false,"issuer_cik":"0001485417","issuer_name":"Xilio Therapeutics, Inc.","issuer_ticker":"XLO","issuer_name_source":null,"issuer_url":"/issuer/0001485417","owner_cik":"0001485417","owner_name":"Shannon James Samuel","owner_display_name":"Shannon James Samuel","owner_url":"/insider/0001485417","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45000.0,"shares_display":"45,000","price_per_share":0.686,"price_display":"0.69","price_state":"stated","total_value":30870.0,"total_display":"30,870.00","total_whole":"30,870","shares_owned_after":45000.0,"shares_owned_after_display":"45,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":5374589,"accession":"0001209191-21-016913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-016913","line_url":"/filing/0001209191-21-016913#line-2","is_derivative":false,"issuer_cik":"0001485417","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001485417","owner_cik":"0001485417","owner_name":"Shannon James Samuel","owner_display_name":"Shannon James Samuel","owner_url":"/insider/0001485417","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7232.0,"shares_display":"7,232","price_per_share":91.2971,"price_display":"91.30","price_state":"stated","total_value":660260.6272,"total_display":"660,260.63","total_whole":"660,261","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":8677252,"accession":"0001209191-19-049534","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-049534","line_url":"/filing/0001209191-19-049534#line-4","is_derivative":false,"issuer_cik":"0001485417","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001485417","owner_cik":"0001485417","owner_name":"Shannon James Samuel","owner_display_name":"Shannon James Samuel","owner_url":"/insider/0001485417","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":26.19,"price_display":"26.19","price_state":"stated","total_value":248805.0,"total_display":"248,805.00","total_whole":"248,805","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-13","scope":"insider"},{"id":8677248,"accession":"0001209191-19-049534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049534","line_url":"/filing/0001209191-19-049534#line-2","is_derivative":false,"issuer_cik":"0001485417","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001485417","owner_cik":"0001485417","owner_name":"Shannon James Samuel","owner_display_name":"Shannon James Samuel","owner_url":"/insider/0001485417","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15500.0,"shares_display":"15,500","price_per_share":26.5891,"price_display":"26.59","price_state":"stated","total_value":412131.05,"total_display":"412,131.05","total_whole":"412,131","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840233","name":"Xilio Therapeutics, Inc.","url":"/issuer/0001840233","role":"Director","n_filings":2,"first_seen":"2025-06-18","last_seen":"2026-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001492426","name":"Horizon Therapeutics Public Ltd Co","url":"/issuer/0001492426","role":"Director","n_filings":2,"first_seen":"2019-09-13","last_seen":"2021-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001485417","retrieved_at":"2026-08-26T19:42:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}